Impacts on lung surgery of the removal of race-correction in lung pulmonary function tests
Race-correction for spirometry, a type of pulmonary function test, is commonly done in medical institutions across the United States.
Aug 22, 2023
0
0
Race-correction for spirometry, a type of pulmonary function test, is commonly done in medical institutions across the United States.
Aug 22, 2023
0
0
For patients with non-small cell lung cancer (NSCLC) ineligible for platinum-based chemotherapy, first-line atezolizumab monotherapy is associated with improved overall survival compared to single-agent chemotherapy, according ...
Aug 15, 2023
0
4
Nonsmokers who develop lung cancer can be treated effectively with new drugs, but their tumors refuse to surrender without a fight. The drugs stop working in the long term because the tumors acquire secondary mutations that ...
Aug 9, 2023
0
55
People exposed to a wildfire within a year after having lung cancer surgery have significantly lower chances of survival compared to lung cancer patients who are not exposed to wildfires, researchers from Emory University, ...
Aug 1, 2023
0
26
With cancer rates rising throughout sub-Saharan Africa—home to 1.1 billion people, or about 14% of the world's population—researchers with the Botswana-Rutgers Partnership for Health are seeking solutions.
Jul 18, 2023
0
1
While pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this therapy. Treatment failure, researchers say, is often caused by differences in ...
Jul 13, 2023
0
16
An accurate tool that is readily available could be used to predict whether frail patients are likely to survive intensive cancer treatments such as chemotherapy, according to researchers from the University of Surrey.
Jun 26, 2023
0
0
One of the big reasons that cancer is difficult to treat is that patients respond to treatments differently, and these differences can rarely be anticipated. In most cases, determining whether and how a patient will respond ...
Researchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib showed promising activity suppressing cancer growth not only within the lungs but also in brain metastases for patients ...
Jun 16, 2023
0
28
A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial results presented on Sunday.
Jun 5, 2023
0
91